Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
7. 00
-0.02
-0.2849%
$
405.81M Market Cap
- P/E Ratio
593% Div Yield
777,500 Volume
-2.23 Eps
$ 7.02
Previous Close
Add Transaction
Day Range
6.87 7.17
Year Range
4 7.54
Want to track ABEO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Abeona Therapeutics Inc. (ABEO) Statistics

Valuation metrics

Market Cap 405.81M
Enterprise value 360.77M
Trailing P/E (ttm) 5.45
Forward P/E 19.26
PEG ratio 0.02
Price/Sales (ttm) 27.44
Price/Book (mrq) 2.73
Enterprise Value/Revenue 24.81
Enterprise Value/EBITDA 4.91

Overview

Shares outstanding 56.87M
Float 36.34M
Shares short 16.49M
% Held by insiders 0.17%
% Held by institutions 0.71%
Average volume (10 days) 1.46M
Average volume (90 days) 1.23M

Price summary

52-Week low 4
52-Week high 7.54
Beta 1.34
50-Day moving average 6.37
200-Day moving average 5.33

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 5 Jul 2022

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 4.55%
Operating margin -6.38%

Operational effectiveness

Return on assets 0.33%
Return on equity 0.41%

Income Statement

Revenue (ttm) 14.54M
Revenue per share (ttm) 0.26
Quarterly revenue growth (yoy) 0.61%
Gross profit (ttm) -18.01M
EBITDA 72.45M
Net income to common (ttm) 66.14M
Diluted EPS (ttm) 1.17
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 168.27M
Total cash per share (mrq) 2.97
Total debt (mrq) 23.17M
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 5.89%
Book value per share (mrq) 2.56

Cash Flow

Cash flow statement -77.73M
Levered free cash flow (LFCF) -56.59M